Safety Profile and Adverse Events of Special Interest for Surufatinib in Chinese Patients with Advanced Extra-Pancreatic Neuroendocrine Tumors: Analysis of the Phase 3 SANET-ep Trial

J. Li,J. Xu, Z. Zhou, C. Bai, Y. Chi,Z. Li, N. Xu,E. Li,T. Liu, Y. Bai, S. Guan, L. Shen

NEUROENDOCRINOLOGY（2020）

引用 0|浏览1